Specificity analysis of the target antigen, an altered form of vimentin called, ecto-domain vimentin (EDV), shows it to be limited to cell surface expression on cancer cells (Glassy, 2020; Babic et al., 2019). The gene discussed is VIM; the disease is cancer.